The Drug-Delivery Technology Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the drug-delivery technology has experienced significant growth recently. It is projected to increase from $48.95 billion in 2024 to $54.74 billion in 2025, with a compound annual growth rate (CAGR) of 11.8%.
The global market for drug-delivery technology is projected to grow to $84.46 billion by 2029, with a compound annual growth rate (CAGR) of 11.5%.
Download Your Free Sample of the 2025 Drug-Delivery Technology Market Report and Uncover Key Trends Now!The key drivers in the Drug-Delivery Technology market are:
• Rise in personalized medicine
• Increasing number of regulatory approvals
• Growth in the adoption of smart drug delivery systems
• Increased preference for biodegradable drug carriers
The drug-delivery technology market covered in this report is segmented –
1) By Type: Oral, Injectable, Topical, Ocular, Nasal, Pulmonary, Transmucosal, Implantable
2) By Application: Cardiovascular Diseases, Oncology, Urology, Diabetes, Central Nervous System (CNS), Ophthalmology, Infections, Other Applications
3) By End User: Hospitals, Clinics, Diagnostic Centers, Home Care Settings, Other End Users
The key trends in the Drug-Delivery Technology market are:
• The application of nanotechnology in drug delivery is an emerging trend.
• Patient-centric delivery systems are becoming increasingly popular.
• Inhalation therapies are shaping the future of the drug-delivery technology market.
• The integration of artificial intelligence and bioprinting for drug delivery are major upcoming trends.
Major companies in the Drug-Delivery Technology market are:
• Merck & Co. Inc.
• AbbVie Inc.
• Bayer AG
• Sanofi S.A.
• AstraZeneca Plc
• Novartis AG
• GlaxoSmithKline Plc.
• Cipla Limited
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals, Inc.
• Vertex Pharmaceuticals Incorporated
• Chiesi Farmaceutici S.p.A.
• United Therapeutics Corporation
• Mallinckrodt Pharmaceuticals Plc.
• Lupin Pharmaceuticals, Inc.
• Glenmark Pharmaceuticals Limited
• Alkermes plc.
• Halozyme Therapeutics Inc.
• Sunovion Pharmaceuticals Inc.
• Circassia Pharmaceuticals Plc.
North America was the largest region in the drug-delivery technology market in 2024